The effect of recombinant human granulocyte/macrophage-colony- stimulating factor (rHu GM-CSF) and rHu G-CSF administration on neutrophil chemiluminescence assay in patients following cyclic chemotherapy

Cancer Immunology Immunotherapy

Volumn 47, Issue 3, 1998, Pages 176-181

  Aslan, Mutay ^a   Yucel, Gultekin ^a   Bozcuk, Hakan ^a   Savas, Burhan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Granulocyte colony stimulating factor; Granulocyte macrophage colony stimulating factor; Neutrophil

Indexed keywords

COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; AGED; ARTICLE; CELL FUNCTION; CHEMOLUMINESCENCE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MALE; METASTASIS; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; SUPERINFECTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMILUMINESCENT MEASUREMENTS; FEMALE; FILGRASTIM; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; NEUTROPENIA; NEUTROPHILS; RECOMBINANT PROTEINS; RESPIRATORY BURST;

EID: 0031796117     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050518     Document Type: Article

References (23)

1. Aglietta M, Piacibello W, Pasquino P, Sanavio F, Stacchini A, Volta C, Monteverde A, Fuhini L, Morelli S, Severino A (1994) Rationale for the use of GM-CSF in oncology. Semin Oncol 6 [Suppl 16]:5
2. Cadenas E, Sies H (1984) Low-level chemiluminescence as an indicator of singlet molecular oxygen in biological systems. Methods Enzymol 105:221
3. De Chatelet RL, Long DG, Shirly SP (1982) Mechanism of luminol-dependent chemiluminescence of human neutrophils. J Immunol 129:1589
4. Gasson JC, Weisbart RH, Kaufmun SE, Clark SC, Hewick RM, Wong GG, Golde DW (1984) Purified human granulocyte-macrophage colony stimulating factor: direct action on neutrophils. Science 226:1389
5. Glaspy JA, Bleecker G, Crawford J (1993) The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health costs associated with cancer chemotherapy. Eur J Cancer 29 A [Suppl 7]:23
6. Hamm JT, Schiller J, Oken MM (1993) Dose ranging study of recombinant human granulocyte-macrophage colony stimulating factor in small cell lung cancer. Proc Am Soc Clin Oncol 12:335
7. Hoekman K, Wagstaff J, Groeningen CJ van, Vermorken JB, Boven E, Pinedo HM (1991) Effects of recombinant human granulocyte-macrophage colony stimulating factor on myelo-suppression induced by multiple cycles of high dose chemotherapy in patients with advanced breast cancer. J Natl Cancer Inst 83:1546
8. Kitagawa S, Yuo A, Souza ML, Saito M, Miura Y, Takuku F (1987) Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide. Biochem Biophy Res Commun 144:1143
9. Lieno L, Nuutila J, Pelliniemi T, Razamaki A (1993) Human recombinant GM-CSF selectively primes receptor mediated respiratory burst of neutrophils in vitro. Immunol Lett 38:26
10. Marty M, Extra JM (1996) Fundamentals: what is 6 μ-CSF? In: Marty M (ed) Manual of GM-CSF. Blackvvell Science, Oxford, p 3
11. Nagata S, Tsuchiya M, Asuno S, Kaziro Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda M, Nomura H (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319:415
12. Olcay Y (1983) Chemotaxis in childhood. Pediatr Res 17:183
13. Ozer H (1996) American Society of Clinical Oncology Guidelines for the Clinical Use of Hematopoeitic Colony-Stimulating Factors. Curr Opin Hematol 3:3
14. Roilides E, Pizzo AP (1993) Perspectives on the use of cytokines in the management of infectious complications of cancer. Clin Infect Dis 17 [Suppl 2]:385
15. Sieff CA (1987) Hematopoietic growth factors. J Clin Invest 79:1549
16. Souza LM., Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Bruszewski J, Lu H, Chen KK (1986) Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232:61
17. Sullivan GW, Carper HT, Mandell GL (1993) The effect of three human recombinant hematopoietic growth factors (granulocytes-macrophage colony stimulating factor, granulocytes-colony stimulating factor, and interleukin-3) on phagocyte oxidative activity. Blood 81:1863
18. Tanimura M, Kobuchi H, Utsumi T, Yoshioka T, Shininhi K, Yukitoshi F, Utsumi K (1992) Neutrophil priming by granulocyte colony stimulating factor and its modulation by protein kinase inhibitors. Biochem Pharmacol 44:1145
19. Thomas VL, Sanford BA, Driscoll MS, Casto TD, Ramamurthy SR (1988) Luminol-dependent chemiluminescence assay for phagocytic function. J Immunol Methods 111:227
20. Web Z, Glodstein IM (1987) Basic and clinical immunology. In: Stitas DP, Stobo JD, Wells JV (eds) Phagocytic cells, chemotaxis and effector functions of macrophages and granulocytes. Lange Medical Publications, USA, p 96
21. Weisbart RH, Golde DW, Gasson JC (1986) Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol 137:3584
22. Williams MA, Kelsey SM, Collins PW, Gutteridge CN, Newland AC (1995) Administration of rHuGM-CSF activates monocyte reactive species secretion and adhesion molecule expression in vivo in patients following high-dose chemotherapy. Br J Haematol 90:31
23. Wong GG, Witek JS, Temple PA, Wilkens KM, Leary AC, Luxenberg DP, Jones SS, Brown EL, Kay RM, Orr EC (1985) Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228:810